37 /100
MEDIUM RISK
Score updated Apr 13, 2026

ESPR

Esperion Therapeutics, Inc. — Stock Dilution Tracker

Track ESPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track ESPR — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
50
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
27%
🔁 Convertible Conversion 40%
• Significant convertible debt: 17% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split 15%
• 52-week low $0.69 has breached $1
📜 Warrant Exercise 15%
• Warrant overhang: 14.4% of shares outstanding
🔔 Track ESPR — Get forecast alerts →
💹 Market Data
Market Cap$557.28M
Shares Outstanding256.81M
Float254.56M
Cash$167.85M
Debt$548.00M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 39.6% shares (2025Q4 vs prior)
200 institutional holders · 157.06M shares
#1 BlackRock, Inc. 17.68M shares
#2 VANGUARD GROUP INC 14.95M shares
#3 Two Seas Capital LP 11.90M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest33.13M
Days to Cover7.0
% of Float13.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2025
8-K 8K EVENT Apr 02, 2026
4 INSIDER TRANSACTION Mar 18, 2026
4 INSIDER TRANSACTION Mar 18, 2026
Full SEC filing analysis available with free account
📰 Recent News
Track ESPR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ESPR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required